Komori
Olympus (7733) · PolicyAdvancedLatest Governance (2026-06-26): "Reframed"

CSR Priority Areas Focused on Healthcare and Health

First written in FY2016. 9 of 16 entries say "Advanced", first in FY2017. Latest entry: 2026-06-26.

16entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018AdvancedFY2021 – FY20222016: 120162017: 120172018: 120182019: 020192020: 120202021: 220212022: 120222023: 120232024: 320242025: 220252026: 32026
Same theme, other companies
Identification and Management of Key Sustainability Issues (Materiality)A theme 159 companies write about · 0 as a headwind · 161 as a tailwind

The whole theme swung hardest in 2020: 2 of 21 companies on the "Worse" side.

16 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 159 companies compared. The sentences above are computed from all 159.
Full recordFilings, disclosures and news, newest first
  1. 2026-06-26ReframedGovernance

    「The management strategy announced in November 2025 sets out three priorities—“Growth through Innovation,” “Simplification,” and “Responsible Behavior”—and positions the promotion of ESG as one of the key initiatives under “Responsible Behavior.”」

    Positions ESG as a key initiative under “Responsible Behavior” in the new management strategy announced in November 2025.
  2. FY2026AdvancedAnnual report

    「In the fiscal year ending March 2026, we formulated a new ESG strategy based on the previous ESG strategy, with the fiscal year ending March 2027 as its first year.」

    For ESG, formulated a new ESG strategy with the fiscal year ending March 2027 as its first year while maintaining the previous 6 materiality areas and 24 materiality topics, and reviewed the KPIs and targets.
  3. 2026-03-30RestatedGovernance

    「These “6 Focus Areas” and “24 Materiality Topics” are intended to integrate with the management and business activities of our Group and represent our commitment to contributing broadly to the resolution of social issues through these activities.」

    Reconfirms the positioning of the 6 Focus Areas and 24 Materiality Topics as integrated with management and business activities.
  4. FY2025AdvancedAnnual report

    「From the fiscal year ending March 2025, we reviewed the structure for evaluating executive compensation performance, which had previously been based solely on the external DJSI indicator, and adopted an evaluation system that enables a comprehensive assessment by also incorporating performance evaluations based on the KPIs and targets established under our ESG strategy.」

    Shifted ESG evaluation from a DJSI-only assessment to a comprehensive executive compensation assessment combining the company's own KPIs and targets.
  5. FY2025ReframedAnnual report

    「As a result, the <r0>25 Materiality Topics</r0> have been reorganized into <r1>24 Materiality Topics</r1>.」

    While maintaining the 6 materiality areas, reorganized the ESG materiality topics from 25 to 24.
  6. FY2025-H1AdvancedAnnual report

    「Broad provision of access to healthcare and improved outcomes; provision of HCP training programs to achieve health equity in the targeted developing countries and regions (colorectal cancer); 36–37 (number of programs); a healthy organizational culture; global percentage of women in management positions: 28.5%–29.6%; contributing to decarbonization and the realization of a circular society in collaboration with society; reduction in CO2 emissions from the company's own facilities (Scope 1 & 2): -68% to -70% (reduction versus the fiscal year ended March 2020); DJSI: selection for the DJSI World Index」

    Specified access to healthcare, the percentage of women in management positions, Scope 1 and 2 emissions, and DJSI World as evaluation indicators and targets for the fiscal year ending March 2027 under ESG and materiality topics.
  7. FY2024AdvancedAnnual report

    「In the fiscal year ended March 2024, we reviewed the structure for evaluating executive compensation performance, which had previously been based solely on the external DJSI indicator, and considered an evaluation structure that would enable a comprehensive assessment by also incorporating performance evaluations based on the KPIs and targets established under our ESG strategy. From the fiscal year ending March 2025, while continuing to use the DJSI, an objective external evaluation indicator, as one of the measures of ESG activities, we will advance those activities based on comprehensive performance indicators by adding performance evaluations based on the KPIs and targets of the ESG strategy's <r0>flagship initiatives</r0>.」

    Announced a policy to revise ESG evaluation from a DJSI-only assessment to a comprehensive assessment incorporating the company's own KPIs and targets.
  8. FY2024AdvancedAnnual report

    「Under this new governance structure, an ESG Committee, composed mainly of the heads of each business and functional division, has been established to promote the execution and monitoring of ESG strategy. Theme-specific working groups have also been set up under the committee for issues requiring cross-functional efforts, and are advancing the implementation of the strategy.」

    Established the ESG Committee and theme-specific working groups, thereby formalizing the system for executing and monitoring ESG strategy. The ratio of external ESG evaluation-linked compensation in executive remuneration is scheduled to increase from 10% to 20% in the fiscal year ending March 2025.
  9. FY2023ReframedAnnual report

    「The company newly reorganised the former “6 ESG areas” and “5 material issues” into “6 Focus Areas” and identified “25 Materiality Topics” under them.」

    The company reorganised its former ESG areas and material issue framework into 6 Focus Areas and 25 Materiality Topics, and established priorities, KPIs and targets.
  10. FY2022AdvancedAnnual report

    「The company has established the Dow Jones Sustainability Indices (DJSI), a leading global ESG investment index, as one of the evaluation metrics for executive compensation. The company first became part of the “World Index” in the DJSI in 2021 and has been included in the “Asia/Pacific Index” for 3 consecutive years.」

    The company described specific implementation and results for its ESG and materiality initiatives, including the executive responsible for ESG, the incorporation of the DJSI into executive compensation and its first inclusion in the DJSI World Index.
  11. FY2022-Q1AdvancedAnnual report

    「The evaluation metrics for PSUs comprise operating profit, relative TSR and ESG metrics, with the weighting as follows: operating profit 40% relative TSR 40% ESG 20%」

    The company incorporated ESG into the evaluation metrics for long-term incentive compensation and specified a framework weighting operating profit at 40%, relative TSR at 40% and ESG at 20%.
  12. FY2021AdvancedAnnual report

    「In May 2021, the company added the environmental perspective of “contributing to the realisation of a decarbonised, circular society in harmony with society,” bringing the number of Olympus materialities to five. To promote ESG, the company established a new executive position responsible for ESG in April 2021, built a system for setting KPIs in its medium- to long-term business plan, and is working to strengthen these initiatives.」

    The company expanded its four former materialities to five by adding decarbonisation and a circular society, and introduced an executive responsible for ESG and a KPI management system.
  13. FY2020ReframedAnnual report

    「Among these, the company identified the following four initiatives to strengthen and promote ESG: providing high-quality healthcare widely and contributing to the health of all people; focusing on compliance and product quality and safety; responsible procurement; and strengthening the promotion of diversity and inclusion.」

    The company revised the wording and priority areas from the former four social contribution areas to stronger ESG initiatives centred on healthcare quality, compliance and quality and safety, responsible procurement, and diversity and inclusion.
  14. FY2018RestatedAnnual report

    「Under the Olympus Group Corporate Citizenship Policy, the group has designated four priority areas, “Healthcare and Health,” “Culture and the Arts,” “The Global Environment” and “Science and Technology,” and conducts social contribution activities, including those initiated by officers and employees.」

    The company reconfirmed the four CSR and social contribution priority areas and activities led by officers and employees.
  15. FY2017AdvancedAnnual report

    「To ensure separation from and transparency regarding recipient organisations for these donations and grants, the company established rules and newly set up a Grants Review Committee, thereby ensuring a high level of transparency in its donation and grant-making activities.」

    In addition to activities in the four CSR priority areas, the company established a Grants Review Committee to ensure transparency in donations and grants.
  16. FY2016First statedAnnual report

    「Under the Olympus Group Social Contribution Policy, the group has designated four priority areas, “Healthcare and Health,” “Culture and the Arts,” “The Global Environment” and “Science and Technology,” and conducts social contribution activities, including those initiated by officers and employees.」

    The company designated four priority areas and carried out initiatives such as disseminating information on endoscopy and supporting colorectal cancer screening.
Moved together

"Active Investment in the Medical Business and Expansion of Growth Areas" moved the same way as this thread, in the same document, in 7 of its 14 moves.

766666★123456
  1. ★This thread
  2. 1Active Investment in the Medical Business and Expansion of Growth Areas7×
  3. 2Establishment of a Company-Wide Quality Management System6×
  4. 3Further expansion of operations centered on the healthcare business6×
  5. 4Annual dividend increased to ¥176×
  6. 5Organization-Wide Strengthening of Information Security6×
  7. 6Reducing Environmental Impact and Contributing to a Sustainable Society6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Olympus yet. It last moved in the Governance of 2026-06-26: "Reframed".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
CSR Priority Areas Focused on Healthcare and Health | OLYMPUS CORPORATION (7733) | Komori